Sierra Leone: Stats SL to Collaborate With John Hopkins University On Ebola Survivors Study

[Concord] Stats SL is all set to collaborate with the John Hopkins University, which is a private research university in Baltimore, Maryland in the United States, to conduct an Ebola survivors study
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news

Related Links:

(Natural News) The Ebola virus disease (EVD) is a rare but highly contagious disease caused by Zaire ebolavirus, or simply the Ebola virus. Due to the high fatality rate associated with EVD, the Ebola virus is considered one of the scariest human pathogens today. Despite efforts to develop treatments, there is still no cure for EVD....
Source: - Category: Consumer Health News Source Type: news
[Vanguard] Acting Chairman of the Economic and Financial Crimes Commission, EFCC, Ibrahim Magu, yesterday said that the commission arrested about 500 suspected internet fraudsters within six months.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Nebraska's state slogan "Honestly, it's not for everyone," should have an asterisk, because everyone with even the trickiest disease seems welcome at Nebraska's largest medical facility.
Source: - Health - Category: Consumer Health News Source Type: news
Source: American College of Emergency Physicians (ACEP). Published: 2/18/2020. This one-hour webinar, co-sponsored by the American Association of Medical Colleges (AAMC), Emergency Nurses Association (ENA), and National Ebola Training and Education Center (NETEC), features experts who discuss the current state of the 2019 novel coronavirus (COVID-19) and share identification, isolation, and treatment strategies for symptomatic patients. They review how to identify and isolate, and notify the proper officials, if a patient with symptoms and epidemiological risk presents at points of entry to health care staff. They also di...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news
Antibody-based therapies are a promising treatment option for managing ebolavirus infections. Several Ebola virus (EBOV)-specific and, more recently, pan-ebolavirus antibody cocktails have been described. Here, we report the development and assessment of a Sudan virus (SUDV)-specific antibody cocktail. We produced a panel of SUDV glycoprotein (GP)-specific human chimeric monoclonal antibodies...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Biological Sciences Source Type: research
The director of the Centers for Disease Control and Prevention ’s Division of Global Health Protection talks about the coronavirus and her organization’s efforts to keep people safe when they travel.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Travel and Vacations Coronavirus (2019-nCoV) Centers for Disease Control and Prevention Epidemics SARS (Severe Acute Respiratory Syndrome) Ebola Virus World Health Organization China Wuhan (China) Nancy Knight Source Type: news
Source: Atlantic Journal of Communication - Category: Psychiatry & Psychology Authors: Source Type: research
Authors: Graul AI, Pina P, Tracy M, Sorbera L Abstract Highlights of our annual review of new approvals and launches on global drug markets include the approval and launch of Trikafta, the most widely applicable treatment to date for cystic fibrosis; approval of the first Ebola vaccine for general (rather than emergency) use; the pilot rollout in three African countries of the world's first malaria vaccine; approval of a new treatment option for multidrug-resistant bacterial infections; and the approval and launch in China of the first new drug to treat Alzheimer's disease in more than a decade. Several new immune ...
Source: Drugs of Today - Category: Drugs & Pharmacology Tags: Drugs Today (Barc) Source Type: research
[UN News] Four countries in Africa have licensed an Ebola vaccine to "cement hard-fought progress" in keeping their people safe from the deadly disease, the UN health agency said on Friday.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[WHO] The Democratic Republic of the Congo (DRC), Burundi, Ghana and Zambia have licensed an Ebola vaccine, just 90 days after World Health Organization (WHO) prequalification. Registration of the vaccine is expected in additional countries in the coming weeks.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
More News: African Health | Ebola | John Hopkins University | Sierra Leone Health | Study | USA Health